A Special Day for a Special Cause
This Giving Tuesday, please support us. Your donations directly help to keep our information and support services free and accessible to everyone, everywhere.
Sofdra™ Gel Gains FDA Approval.
For the first time in six years there is a new prescription, at-home, and self-applied treatment for primary axillary hyperhidrosis (extreme sweating in the armpits). Sofdra™ was recently approved by the U.S. FDA, and we’ve got the most complete and up-to-date information on it here.
WHO Expands Global Access to Hyperhidrosis Education: A Game-Changer for Medical Professionals and Patients
In a significant step toward improving the lives of individuals living with hyperhidrosis, the World Health Organization (WHO) has partnered with the International Hyperhidrosis Society (IHhS) to make two groundbreaking courses available to healthcare providers and patients around the world.
November is Hyperhidrosis Awareness Month: Let's Spread the Word!
November is Hyperhidrosis Awareness Month—a time to bring attention to a condition affecting nearly 5% of the global population. For those living with hyperhidrosis, excessive sweating can greatly impact daily life, confidence and emotional well-being.
Your voice holds the key to shaping our future
In the dynamic realm of product development, savvy teams strive to pinpoint genuine needs for their innovations. But the truly astute companies go beyond mere inquiry; they are curious, listen intently, and are ready to embrace unexpected revelations.
Latest Blogs
